Fresenius Medical Care AG & Co. KGaA (FMS) posted a 39% drop in first-quarter 2013 net income attributable to shareholders to $225.5 million, from last year's $370.5 million. Earnings per ordinary share for the period were $0.74, and earnings per ordinary ADS amounted to $0.37, a 39.6% decrease compared with the prior year.
Operating income or EBIT slid 2% to $493 million, from $503 million in the first quarter of 2012.
However, net revenue for the quarter advanced by 6.6% to $3.46 billion, from $3.25 billion a year ago, and organic revenue growth worldwide was 4%.
For 2013, the company confirmed its revenue and earnings outlook. Full-year revenue is estimated to grow to more than $14.6 billion, translating into a growth rate of more than 6%, while net income attributable to shareholders of Fresenius Medical Care is expected to be between $1.1 billion and $1.2 billion.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.